Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial
28 August 2017 (11:18 - 11:28)
Organised by:
About the speaker
Thomas Jefferson University Hospital, Philadelphia (United States of America)
17 More presentations in this session
Access the full session
The Event
ESC Congress 2017
28 August 2017
11:18 CET
